MENU

EDIT Editas Medicine Forecast, Technical & Fundamental Analysis

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDIT is expected to report earnings to rise 3.38% to -26 cents per share on August 05

Editas Medicine EDIT Stock Earnings Reports
Q2'26
Est.
$-0.27
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.17
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.23
The last earnings report on May 05 showed earnings per share of -25 cents, beating the estimate of -26 cents. With 341.73K shares outstanding, the current market capitalization sits at 427.39M.
A.I. Advisor
published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
87
Web
https://www.editasmedicine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATGAX46.90N/A
N/A
Cantor Fitzgerald Equity Opp A
HBGIX24.36N/A
N/A
Hartford Disciplined Equity HLS IB
EIIFX12.82N/A
N/A
Eaton Vance Balanced I
GPGOX3.82N/A
N/A
Grandeur Peak Global Opportunities Inv
GQGRX18.76N/A
N/A
GQG Partners Emerging Markets Equity R6

EDIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRBU. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+3.53%
CRBU - EDIT
64%
Loosely correlated
+0.18%
BEAM - EDIT
61%
Loosely correlated
+4.07%
PRME - EDIT
58%
Loosely correlated
+4.33%
NTLA - EDIT
57%
Loosely correlated
+0.51%
CRSP - EDIT
56%
Loosely correlated
+0.50%
More
Editas Medicine (EDIT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com